![Sally Dewhurst](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sally Dewhurst
Directeur/Membre du Conseil chez
Grey Wolf Therapeutics Ltd.
Profil
Sally Dewhurst is currently a Director at Grey Wolf Therapeutics Ltd., a Principal at Oxford Science Enterprises PLC, and a Board Member at Alethiomics Ltd. Previously, she was a Board Observer at DJS Antibodies Ltd. Ms. Dewhurst graduated from the University of Durham in 2011.
Postes actifs de Sally Dewhurst
| Sociétés | Poste | Début |
|---|---|---|
Grey Wolf Therapeutics Ltd.
 Grey Wolf Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops next generation immuno-oncology drugs | Directeur/Membre du Conseil | 24/01/2023 |
Oxford Science Enterprises PLC
 Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises invests in companies located in the United Kingdom. The firm targets companies operating in the fields of health tech, deep tech, and life sciences sectors. It provides financing for seed and early stage capital requirements with an investment size of GBP 0.1 – 10 million. | Private Equity Investor | 01/07/2023 |
Alethiomics Ltd.
 Alethiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Directeur/Membre du Conseil | 01/11/2022 |
Anciens postes connus de Sally Dewhurst
| Sociétés | Poste | Fin |
|---|---|---|
DJS Antibodies Ltd.
 DJS Antibodies Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Corporate Officer/Principal | 01/10/2022 |
Formation de Sally Dewhurst
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
16
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of Durham
 University of Durham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford Science Enterprises PLC
Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises invests in companies located in the United Kingdom. The firm targets companies operating in the fields of health tech, deep tech, and life sciences sectors. It provides financing for seed and early stage capital requirements with an investment size of GBP 0.1 – 10 million. | Finance |
DJS Antibodies Ltd.
DJS Antibodies Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Grey Wolf Therapeutics Ltd.
Grey Wolf Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops next generation immuno-oncology drugs | Health Technology |
Alethiomics Ltd.
Alethiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
